Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial

SIMPLE SUMMARY: Approximately 15% of cancer patients have diabetes. These patients often had difficulties in their glycemic control during chemotherapy periods. Patients suffering from these two diseases are often aged 65 years and older, with other cardiovascular comorbidities including renal failu...

Descripción completa

Detalles Bibliográficos
Autores principales: Paris, Justine, Legris, Pauline, Devaux, Madeline, Bost, Stephanie, Gueneau, Pauline, Rossi, Cedric, Manfredi, Sylvain, Bouillet, Benjamin, Petit, Jean-Michel, Pistre, Pauline, Boulin, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526306/
https://www.ncbi.nlm.nih.gov/pubmed/37760514
http://dx.doi.org/10.3390/cancers15184544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526306/
https://www.ncbi.nlm.nih.gov/pubmed/37760514
http://dx.doi.org/10.3390/cancers15184544

Ejemplares similares